Cargando…
Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: a research report
Salivary gland tumors (SGTs) are heterogeneous tumors that range from benign masses to aggressive high-grade carcinomas with distant metastatic potential and limited response to chemotherapy. Mucoepidermoid carcinoma (MEC) accounts for 10% of SGTs and has a poor prognosis. In this research report, w...
Autores principales: | Pharaon, Rebecca R., Gernon, Thomas, Chang, Sue, Vora, Nayana, Villaflor, Victoria M., Bell, Diana, Afkhami, Michelle, Amini, Arya, Sampath, Sagus, Kang, Robert, Maghami, Ellie G., Massarelli, Erminia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059780/ https://www.ncbi.nlm.nih.gov/pubmed/35483880 http://dx.doi.org/10.1101/mcs.a006189 |
Ejemplares similares
-
An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites
por: Pharaon, Rebecca, et al.
Publicado: (2020) -
Prognostic Impact of Primary Tumor Extent and Postoperative Radiation Facility Location in Major Salivary Gland Malignancies
por: Ladbury, Colton, et al.
Publicado: (2022) -
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
por: Sampath, Sagus, et al.
Publicado: (2018) -
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
por: Juarez-Vignon Whaley, Juan Jose, et al.
Publicado: (2023) -
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
por: Juarez-Vignon Whaley, Juan Jose, et al.
Publicado: (2023)